Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia
Event:
EHRA 2023
Topic:
Drug Treatment of Ventricular Arrhythmias
Session:
Ventricular Arrhythmias and SCD - Round 1 - SCD